Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Pain Symptom Manage. 2016 Jun 18;52(1):8–16.e1. doi: 10.1016/j.jpainsymman.2015.10.023

Table 4. Adverse Events.

Attribution Dexamethasone a Placebo b
Days 1-7 Days 8+ Days 1-7 Days 8+
G1 G2 G3 G1 G2 G3 G1 G2 G3 G1 G2 G3
Possible 2 2 0 1 0 0 7 3 1 2 3 2
Probable 3 4 0 3 0 0 3 3 0 4 2 0
Unlikely 2 2 0 1 0 0 8 0 0 2 1 0
Unrelated 0 1 0 0 0 0 1 0 0 0 0 0
Total 7 9 0 5 0 0 19 6 1 8 6 2
a

The possible/probable grade 1 and 2 events in the dexamethasone arm were as follows: anxiety/irritability (n=2), diarrhea (n=1), dyspepsia (n=1), halitosis (n=1) edema (n=3), hiccups (n=1), hot flashes (n=1), hyperglycemia (n=1), hyperhidrosis (n=1), insomnia (n=2) and myalgia (n=1).

b

The possible/probable grade 1 and 2 events in the placebo arm included blurred vision (n=2), dyspepsia (n=2), edema (n=1), fatigue (n=3), flashing (n=1), mouth sores (n=1), taste changes (n=1), hyperglycemia (n=1), fever (n=1), insomnia (n=4), myalgia (n=1), nausea/vomiting (n=4), pain (n=2), rash (n=1) and sore throat (n=1). The grade 3 events in the placebo arm were gastric hemorrhage/ulcer (n=2) and insomnia (n=1).